163 related articles for article (PubMed ID: 36555409)
21. Novel spirobicyclic artemisinin analogues (artemalogues): Synthesis and antitumor activities.
Liu G; Song S; Shu S; Miao Z; Zhang A; Ding C
Eur J Med Chem; 2015 Oct; 103():17-28. PubMed ID: 26318055
[TBL] [Abstract][Full Text] [Related]
22. Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells.
Ooko E; Saeed ME; Kadioglu O; Sarvi S; Colak M; Elmasaoudi K; Janah R; Greten HJ; Efferth T
Phytomedicine; 2015 Oct; 22(11):1045-54. PubMed ID: 26407947
[TBL] [Abstract][Full Text] [Related]
23. Antiproliferative Phenothiazine Hybrids as Novel Apoptosis Inducers against MCF-7 Breast Cancer.
Zhang JX; Guo JM; Zhang TT; Lin HJ; Qi NS; Li ZG; Zhou JC; Zhang ZZ
Molecules; 2018 May; 23(6):. PubMed ID: 29843370
[TBL] [Abstract][Full Text] [Related]
24. Structural optimization and biological evaluation for novel artemisinin derivatives against liver and ovarian cancers.
Zhou Y; Li X; Chen K; Ba Q; Zhang X; Li J; Wang J; Wang H; Liu H
Eur J Med Chem; 2021 Feb; 211():113000. PubMed ID: 33261896
[TBL] [Abstract][Full Text] [Related]
25. Syntheses and Cytotoxicities of Quinazolinone-Based Conjugates.
Le HT; Do KM; Nguyen QP; Doan CNM; Nguyen NA; Phan TT; Tran XTC; Ha QTK; Tran Q; Morita H; Bui HTB
Chem Pharm Bull (Tokyo); 2024; 72(1):61-67. PubMed ID: 38220213
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents.
Luo Y; Wu W; Zha D; Zhou W; Wang C; Huang J; Chen S; Yu L; Li Y; Huang Q; Zhang J; Zhang C
Bioorg Med Chem Lett; 2021 Sep; 47():128230. PubMed ID: 34186178
[TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and biological evaluation of novel hydroxamic acids bearing artemisinin skeleton.
Ha VT; Kien VT; Binh le H; Tien VD; My NT; Nam NH; Baltas M; Hahn H; Han BW; Thao do T; Vu TK
Bioorg Chem; 2016 Jun; 66():63-71. PubMed ID: 27018835
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and Investigation of the Role of Benzopyran Dihydropyrimidinone Hybrids in Cell Proliferation, Migration and Tumor Growth.
Dash AK; Nayak D; Hussain N; Mintoo MJ; Bano S; Katoch A; Mondhe DM; Goswami A; Mukherjee D
Anticancer Agents Med Chem; 2019; 19(2):276-288. PubMed ID: 30179143
[TBL] [Abstract][Full Text] [Related]
30. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agents.
Shao KP; Zhang XY; Chen PJ; Xue DQ; He P; Ma LY; Zheng JX; Zhang QR; Liu HM
Bioorg Med Chem Lett; 2014 Aug; 24(16):3877-81. PubMed ID: 25001482
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and biological evaluation of β-carboline 1,3,4-oxadiazole based hybrids as HDAC inhibitors with potential antitumor effects.
Tian C; Huang S; Xu Z; Liu W; Li D; Liu M; Zhu C; Wu L; Jiang X; Ding H; Zhao Q
Bioorg Med Chem Lett; 2022 May; 64():128663. PubMed ID: 35272009
[TBL] [Abstract][Full Text] [Related]
33. [Design, synthesis and antiproliferative activity in cancer cells of novel dihydropyrazolyl and pyrazolyl artemisinin-phenyl ethers].
Wei YF; Huang M; Li AH; Zhao F; Zhong H; Liu D; Zhao LX
Zhongguo Zhong Yao Za Zhi; 2018 Sep; 43(17):3582-3588. PubMed ID: 30347929
[TBL] [Abstract][Full Text] [Related]
34. The In Vitro Anticancer Activity and Potential Mechanism of Action of 1-[(1R,2S)-2-fluorocyclopropyl]Ciprofloxacin-(4-methyl/phenyl/benzyl-3- aryl)-1,2,4-triazole-5(4H)-thione Hybrids.
Zhang YZ; Liu HL; He QS; Xu Z
Curr Top Med Chem; 2020; 20(16):1493-1498. PubMed ID: 32156237
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and cytotoxic activity of new artemisinin hybrid molecules against human leukemia cells.
Letis AS; Seo EJ; Nikolaropoulos SS; Efferth T; Giannis A; Fousteris MA
Bioorg Med Chem; 2017 Jul; 25(13):3357-3367. PubMed ID: 28456567
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and cytotoxicity of novel artemisinin derivatives containing sulfur atoms.
Xu CC; Wu JJ; Xu T; Yao CH; Yu BY; Liu JH
Eur J Med Chem; 2016 Nov; 123():763-768. PubMed ID: 27537924
[TBL] [Abstract][Full Text] [Related]
37. Novel diosgenin-1,4-quinone hybrids: Synthesis, antitumor evaluation, and mechanism studies.
Li G; Li Q; Sun H; Li W
J Steroid Biochem Mol Biol; 2021 Nov; 214():105993. PubMed ID: 34478831
[TBL] [Abstract][Full Text] [Related]
38. Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.
Chang J; Ren H; Zhao M; Chong Y; Zhao W; He Y; Zhao Y; Zhang H; Qi C
Eur J Med Chem; 2017 Sep; 138():669-688. PubMed ID: 28711702
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
[TBL] [Abstract][Full Text] [Related]
40. GPX4 inhibition synergistically boosts mitochondria targeting nanoartemisinin-induced apoptosis/ferroptosis combination cancer therapy.
Yu H; Li JM; Deng K; Zhou W; Li KH; Wang CX; Wang Q; Wu M; Huang SW
Biomater Sci; 2023 Aug; 11(17):5831-5845. PubMed ID: 37439624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
